title: Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction.
authors: Brad
authors: B
authors: Moriyama
authors: Oluwaseun
authors: O
authors: Falade-Nwulia
authors: Janice
authors: J
authors: Leung
authors: Scott R
authors: SR
authors: Penzak
authors: Caroline
authors: C
authors: JJingo
authors: Xuan
authors: X
authors: Huang
authors: Stacey A
authors: SA
authors: Henning
authors: Wyndham H
authors: WH
authors: Wilson
authors: Thomas J
authors: TJ
authors: Walsh